AL
This company utilizes Generative AI technology to accelerate the adoption of new cancer therapies. Their platform analyzes medical images to predict disease progression and treatment response, informing oncologists for faster patient matching. The core value is enabling earlier access to life-saving treatments, improving patient outcomes significantly.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This company utilizes Generative AI technology to accelerate the adoption of new cancer therapies. Their platform analyzes medical images to predict disease progression and treatment response, informing oncologists for faster patient matching. The core value is enabling earlier access to life-saving treatments, improving patient outcomes significantly.